Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells

• Автори: Azam Akbari (Автор), Azim Akbarzadeh (Автор), Morteza Rafiee Tehrani (Автор), Reza Ahangari Cohan (Автор), Mohsen Chiani (Автор), Mohammad Reza Mehrabi (Автор)
• Формат: Книга
• Опубліковано: Tabriz University of Medical Sciences, 2020-01-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Purpose: Hydroxyurea (HU) is a well-known chemotherapy drug with several side effects which limit its clinical application. This study was conducted to improve its therapeutic efficiency against breast cancer using liposomes as FDA-approved drug carriers. Methods: PEGylated nanoliposomes-containing...